INSM
Insmed IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$21.21B
P/E Ratio
—
EPS
$-5.76
Beta
0.77
52W High
$212.75
52W Low
$90.39
50-Day MA
$125.98
200-Day MA
$154.57
Dividend Yield
—
Profit Margin
-144.40%
Forward P/E
16.37
PEG Ratio
1.09
About Insmed Inc
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Fundamentals
| Revenue (TTM) | $819.56M |
| Gross Profit (TTM) | $670.48M |
| EBITDA | $-949.04M |
| Operating Margin | -65.50% |
| Return on Equity | -294.50% |
| Return on Assets | -31.10% |
| Revenue/Share (TTM) | $3.95 |
| Book Value | $3.25 |
| Price-to-Book | 29.74 |
| Price-to-Sales (TTM) | 25.88 |
| EV/Revenue | 24.8 |
| EV/EBITDA | -6.05 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 229.60% |
| Shares Outstanding | $216.75M |
| Float | $198.30M |
| % Insiders | 0.52% |
| % Institutions | 105.65% |
Historical Volatility
HV 10-Day
79.17%
HV 20-Day
61.23%
HV 30-Day
100.01%
HV 60-Day
78.91%
HV Rank
100.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($198.10 target)
5
Strong Buy17
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026